Black Diamond Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BDTX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Oct 23	BuyUS$934,080	Bellevue Asset Management AG	Company	400,000	US$2.34
05 Jul 23	BuyUS$5,000,000	New Enterprise Associates, Inc.	Company	1,000,000	US$5.00
05 Jul 23	BuyUS$4,679,250	RA Capital Management, L.P.	Company	935,850	US$5.00
30 Jun 23	BuyUS$5,000,000	Bellevue Asset Management AG	Company	1,000,000	US$5.00
27 Jun 23	BuyUS$9,555,036	Bellevue Asset Management AG	Company	1,740,000	US$5.49

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 43.9%.

Top 25 shareholders own 87.38% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.3%	Bellevue Asset Management AG	8,535,839	US$50.4m	4.92%	0.56%
12.7%	T. Rowe Price Group, Inc.	6,675,756	US$39.4m	70%	no data
12.2%	Versant Venture Management, LLC	6,428,564	US$37.9m	0%	11.45%
8.47%	New Enterprise Associates, Inc.	4,448,757	US$26.2m	0%	1.38%
6.71%	RA Capital Management, L.P.	3,525,754	US$20.8m	0%	0.28%
3.9%	Artal Group S.A.	2,046,517	US$12.1m	0%	0.33%
3.71%	The Vanguard Group, Inc.	1,947,093	US$11.5m	-0.84%	no data
3.43%	Tang Capital Management, LLC	1,803,200	US$10.6m	351%	1.18%
2.96%	Verition Fund Management LLC	1,554,629	US$9.2m	-10.4%	0.1%
2.57%	BlackRock, Inc.	1,350,047	US$8.0m	-3.58%	no data
1.74%	David M. Epstein	913,479	US$5.4m	-2.47%	no data
1.56%	JPMorgan Chase & Co, Brokerage and Securities Investments	821,634	US$4.8m	-25.8%	no data
1.41%	Kennedy Capital Management LLC	740,901	US$4.4m	-1.25%	0.09%
1.33%	Driehaus Capital Management LLC	696,969	US$4.1m	0%	0.03%
1.32%	CHI Advisors LLC	695,000	US$4.1m	-3.47%	1.35%
1.06%	Ikarian Capital, LLC	555,572	US$3.3m	0%	0.81%
1.03%	Candriam	540,009	US$3.2m	8%	0.01%
0.96%	Tavistock Life Sciences	506,000	US$3.0m	0%	0.17%
0.86%	Renaissance Technologies LLC	450,400	US$2.7m	36.9%	no data
0.7%	Two Sigma Investments, LP	367,293	US$2.2m	358%	0.01%
0.67%	Geode Capital Management, LLC	350,446	US$2.1m	8.07%	no data
0.53%	Newtyn Management, LLC	280,000	US$1.7m	36.6%	0.21%
0.48%	Parkman Healthcare Partners LLC	253,717	US$1.5m	-51.3%	0.2%
0.42%	Susquehanna International Group, LLP, Asset Management Arm	220,310	US$1.3m	4.25%	no data
0.37%	Bridgeway Capital Management, LLC	192,000	US$1.1m	51.8%	0.02%